📰 Sera Prognostics News
Page 4 - Sera Prognostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sera Prognostics. Real-time updates on events, politics, business and more.
July 28, 2023
Sera Prognostics (NASDAQ:SERA – Get Free Report) and MedTech Acquisition (NASDAQ:MTAC – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, dividends, analyst recommendations and profitability. Analyst Ratings This is a summary of […]
July 21, 2023
Sera Prognostics (NASDAQ:SERA – Get Free Report) and Sonic Healthcare (OTCMKTS:SKHCF – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, earnings and institutional ownership. Institutional & Insider Ownership 29.4% of Sera Prognostics […]
July 21, 2023
Sonic Healthcare (OTCMKTS:SKHCF – Get Free Report) and Sera Prognostics (NASDAQ:SERA – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, risk, institutional ownership, valuation, analyst recommendations and dividends. Institutional and Insider Ownership 31.8% of Sonic Healthcare […]
June 19, 2023
Wilmington, Delaware, United States, June 20, 2023 (GLOBE NEWSWIRE) -- The preeclampsia diagnostics market is projected to experience robust growth, with an estimated CAGR of 3.8% between 2023 and 2031. According to
June 13, 2023
Sera Prognostics (NASDAQ:SERA – Get Rating) and Centogene (NASDAQ:CNTG – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Profitability This table compares Sera Prognostics and Centogene’s net margins, […]
June 9, 2023
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) insider Robert Gardner Harrison sold 5,000 shares of Sera Prognostics stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $3.23, for a total value of $16,150.00. Following the sale, the insider now directly owns 28,500 shares in the […]
June 9, 2023
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) insider Robert Gardner Harrison sold 5,000 shares of Sera Prognostics stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $3.23, for a total transaction of $16,150.00. Following the sale, the insider now directly owns 28,500 shares in the […]
June 8, 2023
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) shares dropped 1.8% during mid-day trading on Monday . The company traded as low as $3.18 and last traded at $3.19. Approximately 10,878 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 813,135 shares. The stock had previously closed at $3.25. […]
June 6, 2023
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) insider Robert Gardner Harrison sold 5,000 shares of Sera Prognostics stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $3.23, for a total transaction of $16,150.00. Following the completion of the sale, the insider now directly owns 28,500 […]
June 1, 2023
Scientific Advisory Board members bring significant global expertise in oncology drug and clinical development ... | June 1, 2023